Genetically engineered Bifidobacterium shows potential for oral delivery of cancer vaccines. A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical findings that warrant further investigation.
- Ponto de atenção: genetically.
- Ponto de atenção: engineered.
- Ponto de atenção: bifidobacterium.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
